Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Abstract Background Despite evidence of a quite large beneficial effect of endovascular treatment (EVT) for ischemic stroke caused by anterior circulation large vessel occlusion, many patients do not recover even after complete recanalization. To some extent, this may be attributable to incomplete m...

Full description

Bibliographic Details
Main Authors: Vicky Chalos, Rob A. van de Graaf, Bob Roozenbeek, Adriaan C. G. M. van Es, Heleen M. den Hertog, Julie Staals, Lukas van Dijk, Sjoerd F.M. Jenniskens, Robert J. van Oostenbrugge, Wim H. van Zwam, Yvo B.W.E.M. Roos, Charles B.L.M. Majoie, Hester F. Lingsma, Aad van der Lugt, Diederik W.J. Dippel, on behalf of the MR CLEAN-MED investigators
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Trials
Subjects:
Ischemic stroke
Acetylsalicylic acid
Heparin
Cerebrovascular disorders
Randomized controlled trial
Endovascular treatment
Online Access:http://link.springer.com/article/10.1186/s13063-020-04514-9

Internet

http://link.springer.com/article/10.1186/s13063-020-04514-9

Similar Items